Index of /~dosen/repository/yustina

[ICO]NameLast modifiedSizeDescription

[PARENTDIR]Parent Directory   -  
[   ]Hibah2015.pdf 2023-02-08 02:24 1.1M 
[   ]Hibah2016.pdf 2023-02-08 02:24 1.4M 
[   ]In-vivo.pdf 2024-05-02 22:15 4.2M 
[   ]PROSIDING-SEMINAR-NA..>2023-02-05 22:47 15M 
[   ]PROSIDING-SEMINAR-NA..>2023-02-05 23:07 12M 
[   ]Poster-indifference.pdf2024-05-02 22:30 597K 
[   ]accumulation.pdf 2023-01-23 23:36 909K 
[   ]aktivitas.pdf 2023-01-23 23:50 1.4M 
[   ]amylase.pdf 2023-09-04 01:47 4.0M 
[   ]antagonistic.pdf 2023-01-23 23:54 1.2M 
[   ]antibacterial.pdf 2023-01-23 23:36 2.0M 
[   ]antibakteri.pdf 2023-01-23 23:51 3.2M 
[   ]anticancer.pdf 2023-01-23 23:47 2.3M 
[   ]antioxidant.pdf 2024-05-02 22:25 23M 
[   ]biflavonoid.pdf 2023-01-23 23:36 5.1M 
[   ]brotowali.pdf 2023-01-23 23:32 1.5M 
[   ]chemometrics.pdf 2023-09-04 02:31 2.3M 
[   ]comparison.pdf 2023-01-23 23:36 2.8M 
[   ]consumer.pdf 2024-05-12 22:25 617K 
[   ]crocatin.pdf 2023-02-01 23:58 797K 
[   ]dissolution.pdf 2023-01-23 23:33 1.6M 
[   ]distribusi.pdf 2023-09-04 22:01 1.0M 
[   ]effect.pdf 2023-01-23 23:47 392K 
[   ]ekstrak.pdf 2023-09-04 01:28 2.4M 
[   ]fagositosis.pdf 2023-01-23 23:54 1.6M 
[   ]farmakognosi.pdf 2023-01-23 23:50 5.3M 
[   ]implementasi.pdf 2023-01-23 23:33 1.4M 
[   ]indifference.pdf 2024-05-02 22:30 1.3M 
[   ]infulence.pdf 2023-01-23 23:33 1.6M 
[   ]inulin.pdf 2023-01-24 02:33 758K 
[   ]isocratic.pdf 2023-01-24 02:40 1.6M 
[   ]kombinasi.pdf 2023-09-04 01:24 1.8M 
[   ]korespondensi-In-viv..>2024-05-02 22:16 342K 
[   ]korespondensi-accumu..>2023-01-23 22:56 1.0M 
[   ]korespondensi-amylas..>2025-04-08 02:50 956K 
[   ]korespondensi-antago..>2023-01-23 23:13 548K 
[   ]korespondensi-antiba..>2023-01-23 22:56 611K 
[   ]korespondensi-antica..>2023-01-23 23:08 287K 
[   ]korespondensi-antiox..>2024-05-02 22:26 232K 
[   ]korespondensi-biflav..>2023-01-23 22:56 951K 
[   ]korespondensi-brotow..>2023-01-27 02:37 673K 
[   ]korespondensi-chemom..>2023-09-04 02:34 442K 
[   ]korespondensi-compar..>2023-01-23 22:56 949K 
[   ]korespondensi-consum..>2024-05-12 21:45 434K 
[   ]korespondensi-crocat..>2023-02-01 23:58 303K 
[   ]korespondensi-dissol..>2023-01-23 22:52 273K 
[   ]korespondensi-effect..>2023-01-23 23:03 853K 
[   ]korespondensi-ekstra..>2023-01-23 23:20 118K 
[   ]korespondensi-fagosi..>2023-01-23 23:27 141K 
[   ]korespondensi-implem..>2023-01-23 22:52 317K 
[   ]korespondensi-indiff..>2024-05-02 22:31 363K 
[   ]korespondensi-influe..>2023-01-23 22:13 160K 
[   ]korespondensi-inulin..>2023-01-23 23:07 172K 
[   ]korespondensi-isocra..>2023-01-23 22:56 472K 
[   ]korespondensi-kombin..>2023-02-01 23:58 233K 
[   ]korespondensi-lidah.pdf2023-01-23 23:21 149K 
[   ]korespondensi-molecu..>2024-05-02 22:31 1.0M 
[   ]korespondensi-potenc..>2023-01-23 23:03 461K 
[   ]korespondensi-potret..>2023-09-04 00:24 138K 
[   ]korespondensi-repell..>2023-01-23 23:10 559K 
[   ]korespondensi-sambil..>2023-01-23 22:52 459K 
[   ]korespondensi-second..>2024-05-02 22:23 1.0M 
[   ]korespondensi-spectr..>2023-01-23 23:03 181K 
[   ]korespondensi-stimuo..>2023-01-23 23:22 134K 
[   ]korespondensi-toxici..>2023-01-23 23:10 250K 
[   ]korespondensi-vivo.pdf 2023-02-01 23:58 338K 
[   ]lidah.pdf 2023-09-04 01:26 1.2M 
[   ]molecular.pdf 2024-05-02 22:28 1.5M 
[   ]peraturan.pdf 2023-02-01 23:58 209K 
[   ]potency.pdf 2023-01-23 23:46 1.3M 
[   ]potret.pdf 2023-09-04 01:26 9.0M 
[   ]regulasi.pdf 2023-01-24 01:23 5.2M 
[   ]repellent.pdf 2023-01-23 23:50 973K 
[   ]sambiloto.pdf 2023-01-23 23:33 1.5M 
[   ]secondary.pdf 2024-05-02 22:17 1.2M 
[   ]similarity-In-vivo.pdf 2024-05-02 22:16 924K 
[   ]similarity-accumulat..>2023-01-23 21:31 795K 
[   ]similarity-ai-amylas..>2024-10-02 04:14 2.0M 
[   ]similarity-ai-chemom..>2024-10-02 04:15 2.3M 
[   ]similarity-ai-molecu..>2024-10-02 04:16 2.3M 
[   ]similarity-ai-second..>2024-10-02 04:16 2.7M 
[   ]similarity-aktivitas..>2023-01-23 21:38 1.2M 
[   ]similarity-amylase.pdf 2023-09-04 01:48 2.2M 
[   ]similarity-antagonis..>2023-01-23 21:47 2.0M 
[   ]similarity-antibacte..>2023-01-23 21:30 1.5M 
[   ]similarity-antibakte..>2023-01-23 21:46 3.4M 
[   ]similarity-anticance..>2023-01-23 21:32 3.9M 
[   ]similarity-antioxida..>2024-05-02 22:26 1.1M 
[   ]similarity-biflavono..>2023-01-23 21:30 5.2M 
[   ]similarity-brotowali..>2023-01-19 20:51 1.0M 
[   ]similarity-chemometr..>2023-09-04 02:52 2.8M 
[   ]similarity-compariso..>2023-01-23 21:31 3.3M 
[   ]similarity-consumer.pdf2024-05-06 01:10 2.2M 
[   ]similarity-crocatin.pdf2023-02-01 23:58 928K 
[   ]similarity-dissoluti..>2023-01-23 21:29 1.0M 
[   ]similarity-effect.pdf 2023-01-23 21:31 2.0M 
[   ]similarity-ekstrak.pdf 2023-01-23 21:49 2.0M 
[   ]similarity-fagositos..>2023-01-23 21:47 2.3M 
[   ]similarity-farmakogn..>2023-01-23 21:36 40M 
[   ]similarity-implement..>2023-01-23 21:00 1.8M 
[   ]similarity-indiffere..>2024-05-02 22:30 1.2M 
[   ]similarity-influence..>2023-01-19 20:53 1.6M 
[   ]similarity-inulin.pdf 2023-01-23 21:31 1.1M 
[   ]similarity-isocratic..>2023-01-23 21:30 2.4M 
[   ]similarity-kombinasi..>2023-02-01 23:58 2.5M 
[   ]similarity-lidah.pdf 2023-09-04 00:13 4.4M 
[   ]similarity-molecular..>2024-05-02 22:30 3.8M 
[   ]similarity-potency.pdf 2023-01-23 21:31 1.3M 
[   ]similarity-regulasi.pdf2023-01-23 21:49 1.5M 
[   ]similarity-repellent..>2023-01-23 21:38 3.1M 
[   ]similarity-sambiloto..>2023-01-23 21:29 1.0M 
[   ]similarity-secondary..>2024-05-02 22:22 1.9M 
[   ]similarity-spectrosc..>2023-01-23 21:31 1.7M 
[   ]similarity-toxicity.pdf2023-01-23 21:46 3.0M 
[   ]similarity-tumbuhan.pdf2024-05-02 22:37 59M 
[   ]similarity-vivo.pdf 2023-02-01 23:58 1.9M 
[   ]spectroscopy.pdf 2023-01-23 23:47 509K 
[   ]surattugas-2015.pdf 2024-05-13 00:11 5.9M 
[   ]surattugas-2016.pdf 2024-05-13 00:11 2.4M 
[   ]surattugas-2023.pdf 2024-05-13 00:11 3.0M 
[   ]toxicity.pdf 2023-01-23 23:51 2.6M 
[   ]tumbuhan.pdf 2024-05-02 22:35 7.2M 
[   ]vivo.pdf 2023-02-01 23:58 4.8M